Advertisement
Novozymes launches Acrylaway to reduce acrylamide which is formed whenstarchy foods are baked, fried or toasted at high temperatures. Acrylamide isunder suspicion of causing cancer.
Advertisement
Health concerns
In 2002, a study by the Swedish National Food Authorities discoveredconsiderable levels of acrylamide in food products such as French fries,biscuits, snacks and crackers. The study raised awareness of acrylamideworldwide. A new enzyme called Acrylaway addresses this problem.
Acrylaway can be applied to a wide range of products opening up for anoverall reduction of average daily intake of acrylamide for consumersworldwide.
"It is a fundamental need for consumers and society that our food is safeand healthy. With the enzyme solution from Novozymes, food manufacturers cannow offer end-consumers food products with reduced worries regardingacrylamide" says Peder Holk Nielsen, Executive Vice President, Sales &Marketing at Novozymes.
Acrylamide is reduced up to 90%
Independent tests show that Acrylaway effectively reduces acrylamidelevels by 50% to 90% in a broad range of foods such as biscuits, crackers,crisp bread and snacks.
"Many food manufacturers globally have already tested Acrylaway and haveshown interest in the product and its ability to substantially reduceacrylamide without changing the taste and appearance of their food product,"Peder Holk Nielsen says.
In November 2006, Novozymes received a consent letter from the US Food &Drug Administration regarding the generally recognized as safe (GRAS) statusof the asparaginase enzyme. In June 2007 Acrylaway was approved by the Danishauthorities and thereby is the first asparaginase that has been safetyevaluated by a national EU authority. Furthermore, Acrylaway became the firstasparaginase product to be evaluated internationally as it received apositive evaluation at a Joint FAO/WHO Expert Committee meeting in June 2007.
For more information on Acrylaway please go tohttp://www.novozymes.com/acrylawayContact: Annegrethe Moller Jakobsen Press coordinator Phone : +45-3079-3050 E-Mail : [email protected]
SOURCE Novozymes Switzerland AG
